comparemela.com

Latest Breaking News On - Westamerica bancorporation - Page 7 : comparemela.com

Westamerica Bancorporation (NASDAQ:WABC) Declares Quarterly Dividend of $0 44

Westamerica Bancorporation (NASDAQ:WABC) Declares Quarterly Dividend of $0 44
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Westamerica Bancorporation (NASDAQ:WABC) Announces Quarterly Dividend of $0 44

Westamerica Bancorporation (NASDAQ:WABC) Announces Quarterly Dividend of $0 44
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Westamerica Bancorporation (NASDAQ:WABC) CEO Sells 15,000 Shares

Westamerica Bancorporation (NASDAQ:WABC – Get Free Report) CEO David L. Payne sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $49.75, for a total value of $746,250.00. Following the sale, the chief executive officer now directly owns 288,689 shares of […]

Westamerica Bancorporation (NASDAQ:WABC) Plans Quarterly Dividend of $0 44

Westamerica Bancorporation (NASDAQ:WABC – Get Free Report) announced a quarterly dividend on Thursday, January 25th, NASDAQ reports. Stockholders of record on Monday, February 5th will be given a dividend of 0.44 per share by the financial services provider on Friday, February 16th. This represents a $1.76 annualized dividend and a dividend yield of 3.66%. The […]

Research Analysts Upgrades for January 27th (AMGN, MORN, MRNS, NEU, NLY, SHOP, SOHU, STKS, VALE, WABC)

Research Analysts’ upgrades for Saturday, January 27th: Amgen (NASDAQ:AMGN) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Morningstar (NASDAQ:MORN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Marinus Pharmaceuticals (NASDAQ:MRNS) was upgraded by analysts at StockNews.com from a sell rating to a hold […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.